Research probes survival gap for native americans on cancer immunotherapy
NCT ID NCT05863052
Summary
This study looks back at medical records to understand how well immunotherapy cancer drugs work for American Indian patients compared to White patients. Researchers will analyze survival times, side effects, and cancer-related deaths in 72 patients who were treated between 2015 and 2021. The goal is to identify any differences in outcomes that could point to healthcare disparities and guide future support programs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arizona Cancer Center at the Unvieristy of Arizona
Tucson, Arizona, 85719, United States
-
Avera Cancer Institute
Sioux Falls, South Dakota, 57105, United States
-
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah, 84112, United States
-
Monument Health Cancer Care Institute
Rapid City, South Dakota, 57701, United States
-
Stephenson Cancer Center
Oklahoma City, Oklahoma, 73117, United States
-
University of New Mexico Comprehensive Cancer Center
Albuquerque, New Mexico, 87102, United States
Conditions
Explore the condition pages connected to this study.